Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.
about
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseMeta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference.Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.
P2860
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@ast
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@en
type
label
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@ast
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@en
prefLabel
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@ast
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@en
P2093
P2860
P356
P1476
Thiopurine methyltransferase a ...... astic leukaemia trial ALL2003.
@en
P2093
Cher S Cartwright
Lynne Lennard
Rachel Wade
P2860
P304
P356
10.1111/BJH.13469
P407
P577
2015-05-05T00:00:00Z